医学
肾单位
肾
肾脏疾病
糖尿病
疾病
内科学
重症监护医学
内分泌学
作者
Hans‐Joachim Anders,John M. Davis,Klaus Thurau
标识
DOI:10.1056/nejmcibr1608564
摘要
This commentary discusses nephron protection in diabetic kidney disease and describes the way in which renin–angiotensin system inhibitors and the sodium–glucose cotransporter 2 inhibitor empagliflozin have renoprotective effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI